High-dose vitamin D therapy and prolonged partial remission of type 1 diabetes — a case report

Read full text Summarise with VIRAT
Authors: Adriana Chader-Gata Garcia, Kristina Cossen, Benjamin Udoka Nwosu
Cited by: 0
References: 31

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Clinical trials demonstrating β-cell protection by high-dose vitamin D supplementation have led to the adoption of adjunctive vitamin D therapy in stage 3 type 1 diabetes (T1D). We present the case of a 12-year-old male child who received high-dose vitamin D therapy from 1-27 months following his diagnosis with T1D. His serum 25-hydroxyvitamin D rose from 25 ng/mL to 65 ng/dL within 3 months and remained >40 ng/mL. Hemoglobin A1c (A1c) decreased from 13.8% at diagnosis to persistently 70% for 24 months, and insulin-dose adjusted A1c (IDAA1c), the clinical marker of partial clinical remission, decreased from 17 to

Fields of Study & Subjects

Diabetes and associated disorders Vitamin D Research Studies Diabetes Management and Research

Publication details

Journal / source
Frontiers in Endocrinology
Volume
17
Pages
1788049–1788049
Publication date
31 March 2026
Language
EN